Bogle Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-28,142
Closed -$6.33M – 326
2017
Q4
$6.33M Buy
+28,142
New +$5.99M 0.47% 86
2017
Q3
– Sell
-19,822
Closed -$3.73M – 305
2017
Q2
$3.73M Sell
19,822
-53,590
-73% -$9.63M 0.27% 120
2017
Q1
$12.1M Buy
+73,412
New +$11.7M 0.85% 44
2016
Q3
– Sell
-43,103
Closed -$5.66M – 376
2016
Q2
$5.66M Buy
+43,103
New +$5.9M 0.39% 94
2015
Q3
– Sell
-56,900
Closed -$9.34M – 378
2015
Q2
$9.34M Buy
+56,900
New +$9.09M 0.7% 48

Other funds holding ELV

Bogle Investment Management's ELV Position: Q1 2018 in Review

Bogle Investment Management sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 28,142 shares — an estimated $6.33M sold.

Bogle Investment Management first reported a position in ELV in Q2 2015 and held it in 5 quarters. The position peaked at $12.1M in Q1 2017. 924 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Bogle Investment Management reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Bogle Investment Management sold 28,142 Elevance Health shares in Q1 2018, an estimated $6.33M.
  • Bogle Investment Management first reported a position in Elevance Health in Q2 2015 and held it in 5 quarters.
  • Bogle Investment Management's Elevance Health position peaked at $12.1M in Q1 2017.
  • 924 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Bogle Investment Management's 13F filing for Q1 2018, filed 14 May 2018.